Emory Innovation Certificate Program
The program is designed to develop and enrich entrepreneurial skills and business knowledge for Emory faculty and staff interested in learning how to bring technologies to market. The program includes speakers from across the Atlanta Innovation ecosystem from Biolocity, Georgia Tech, Goizueta Business School, Georgia Research Alliance, Emory Office of Tech Transfer and others.
Bioentrepreneurship Networking Series
Emory University’s School of Medicine hosts its monthly series every third Thursday of the month from January to June 4:30 pm - 6:00 pm in Emory's Health Sciences Research Building II, 6th floor, Room N600. Come explore captivating case studies and success stories showcasing trailblazing bioentrepreneurs. It’s an unparalleled opportunity to mingle with the brightest minds at the frontier of biological innovation and entrepreneurship. Don’t miss out on this exciting chance to connect, converse, and collaborate. Food is provided and all are welcome to attend.
For questions, contact Cindy Borges: cindy.lynn.borges@emory.edu
Join Us
Thursday, May 15th
4:30-6:00 p.m.
Health Sciences Research Building II
6th floor, N600
Join Emory University’s School of Medicine as it kicks off its first Bioentrepreneurship Networking | Founders Series event, featuring Dr. Gabe A. Kwong! Dr. Kwong is the Robert A. Milton Endowed Chair and Professor of Biomedical Engineering at Georgia Tech and Emory School of Medicine.
A longstanding challenge in medicine is getting drugs to act at the right place and at the right time inside the body. Port Therapeutics was founded by academic co-founders at Georgia Tech, Caltech and MIT to pioneer spatiotemporal therapeutics. Their cutting-edge approach to the design of cell therapies centers on incorporating temperature-sensitive transcriptional switches that can be remotely activated by small changes in temperature using external stimuli - such as radiofrequency or focused ultrasound - applied by medical devices. These thermal switches have been tested in CAR T-cells and shown to enable the localized production of potent modulators (e.g., cytokines, T-cell engagers) to boost anti-tumor responses while limiting systemic exposure, unlocking drugs that were previously undruggable. This talk will share the origin story, investment thesis, and the scientific foundation behind Port Therapeutics and its mission to usher in a new category of spatially and temporally controlled medicines. Time for networking will be allotted, and food will be provided.
Please RSVP to attend the session on Thurs, May 15th from 4:30 – 6:00 pm in HSRB-II, 6th floor, Room N600.